Table 2. Shared Signature Microsatellite Loci.
Percentage of Shared Signature Variant Microsatellite Loci Between Cancer Comparisons | ||||
---|---|---|---|---|
GBM | LGG | MEL | MB | |
BC | 9.3% | 8.5% | 9.4% | 11% |
GBM | - | 12% | 14% | 0.2% |
LGG | - | - | 26% | 33% |
MEL | - | - | - | 32% |
Compared are four cancers with linkage to NTC/NCC lineage (GBM, LGG, MEL, and MB) compared with breast cancer (BC). Described is the relative percentage of signature genotypes that were identified from a shared cohort for any pair-wise comparison. The equation for this analysis is the following: % Common signature loci = ((x–z) / ((y1 + y2)–z)) *100; where x = signature loci shared in both cancers; y1 = total signature loci in cancer1 (i.e. BC, GBM, LGG, or MEL); y2 = total signature loci in cancer2 (i.e. GBM, LGG, MEL, or MB); z = CAML common to both cancers.